(Q41648568)

6 October 2017

title

Bone morphogenetic protein 2 exerts diverse effects on cell growth in vitro and is expressed in human pancreatic cancer in vivo (English)

1 reference

6 October 2017

1 reference

1 reference

1 reference

6

Büchler MW

1 reference

6 October 2017

5

Friess H

1 reference

6 October 2017

Kleeff J

1

1 reference

6 October 2017

Maruyama H

2

1 reference

6 October 2017

Ishiwata T

3

1 reference

6 October 2017

Sawhney H

4

1 reference

6 October 2017

Korc M

7

1 reference

6 October 2017

language of work or name

English

0 references

publication date

1 May 1999

1 reference

6 October 2017

1 reference

6 October 2017

volume

116

1 reference

6 October 2017

issue

5

1 reference

6 October 2017

page(s)

1202-1216

1 reference

Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells

6 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970024-7

Transforming growth factor-beta 2: cDNA cloning and sequence analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970024-7

Identification of another member of the transforming growth factor type beta gene family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970024-7

Complementary DNA sequences of ovarian follicular fluid inhibin show precursor structure and homology with transforming growth factor-beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970024-7

Novel regulators of bone formation: molecular clones and activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970024-7

Bone morphogenetic proteins: multifunctional regulators of vertebrate development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970024-7

Characterization of type I receptors for transforming growth factor-beta and activin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970024-7

Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970024-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970024-7

The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970024-7

TGF-beta signalling from cell membrane to nucleus through SMAD proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970024-7

DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970024-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970024-7

Cancer of the pancreas. 50 years of surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970024-7

Treatment of duct carcinoma of the pancreas with the LH-RH analogue buserelin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970024-7

Low-dose octreotide treatment is not effective in patients with advanced pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970024-7

Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970024-7

Growth inhibition of human pancreatic carcinoma cells by transforming growth factor beta-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970024-7

Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970024-7

The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970024-7

cDNA cloning and genomic structure of human bone morphogenetic protein-3B (BMP-3b)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970024-7

Insulin, transforming growth factors, and substrates modulate growth of guinea pig pancreatic duct cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970024-7

Up-regulation of transforming growth factor (TGF)-beta receptors by TGF-beta1 in COLO-357 cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970024-7

Bone morphogenetic protein-6 expression in normal and malignant prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970024-7

Expression of bone morphogenetic protein messenger RNAs by normal rat and human prostate and prostate cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970024-7

Overexpression of bone morphogenic protein (BMP)-4 mRNA in gastric cancer cell lines of poorly differentiated type

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970024-7

Immunohistochemical detection of bone morphogenetic proteins in bone and soft-tissue sarcomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970024-7

Expression of bone morphogenetic proteins in human osteosarcoma. Immunohistochemical detection with monoclonal antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970024-7

Bone morphogenetic protein type IB receptor is progressively expressed in malignant glioma tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970024-7

Role of growth factors in pancreatic cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970024-7

Opposing BMP and EGF signalling pathways converge on the TGF-beta family mediator Smad1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970024-7

Peptide growth factors are multifunctional

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970024-7

Transfection of the type I TGF-beta receptor restores TGF-beta responsiveness in pancreatic cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970024-7

Enhanced expression of transforming growth factor beta isoforms in pancreatic cancer correlates with decreased survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970024-7

inferred from DOI database lookup

7 January 2021

based on heuristic

MAP kinases ERK1 and ERK2: pleiotropic enzymes in a ubiquitous signaling network

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970024-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0016-5085(99)70024-7

1 reference

6 October 2017

1 reference